Pharmacotherapies For Alcohol And Substance Use Disorders Alliance
Clinical trials sponsored by Pharmacotherapies For Alcohol And Substance Use Disorders Alliance, explained in plain language.
-
Sleep drug shows promise for dual diagnosis of alcoholism and PTSD
Disease control Recruiting nowThis phase 2 study tests whether the sleep medication suvorexant can reduce insomnia in 76 adults aged 21–65 who have both alcohol use disorder and posttraumatic stress disorder. Participants take either suvorexant or a placebo for 14 days while trying to stop drinking. The study…
Phase: PHASE2 • Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a tiny tablet ease both heavy drinking and PTSD?
Symptom relief Recruiting nowThis early-phase study tests whether a sublingual form of dexmedetomidine (BXCL501) is safe and shows promise for treating alcohol use disorder in people who also have PTSD. Ten heavy drinkers with PTSD will take the drug and be monitored for changes in blood pressure, anxiety, a…
Phase: PHASE1 • Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC